Algert Global LLC Sells 74,185 Shares of Integral Ad Science Holding Corp. (NASDAQ:IAS)

Algert Global LLC cut its stake in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) by 15.7% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 397,571 shares of the company's stock after selling 74,185 shares during the quarter. Algert Global LLC owned 0.25% of Integral Ad Science worth $4,298,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. raised its position in Integral Ad Science by 7.0% in the first quarter. Vanguard Group Inc. now owns 8,673,229 shares of the company's stock valued at $86,472,000 after purchasing an additional 566,982 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund bought a new position in Integral Ad Science in the 2nd quarter valued at approximately $4,724,000. Nisa Investment Advisors LLC boosted its position in Integral Ad Science by 449,805.3% during the 2nd quarter. Nisa Investment Advisors LLC now owns 427,410 shares of the company's stock worth $4,154,000 after buying an additional 427,315 shares during the period. abrdn plc grew its holdings in Integral Ad Science by 12.5% during the 3rd quarter. abrdn plc now owns 2,147,656 shares of the company's stock worth $23,216,000 after acquiring an additional 237,930 shares during the last quarter. Finally, Rice Hall James & Associates LLC acquired a new position in Integral Ad Science in the 3rd quarter valued at approximately $1,795,000. 95.78% of the stock is currently owned by institutional investors and hedge funds.

Integral Ad Science Stock Up 0.3 %

Integral Ad Science stock traded up $0.03 during midday trading on Monday, reaching $11.11. The stock had a trading volume of 735,280 shares, compared to its average volume of 1,381,590. The company has a fifty day moving average price of $11.09 and a two-hundred day moving average price of $10.54. Integral Ad Science Holding Corp. has a 12 month low of $7.98 and a 12 month high of $17.53. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $1.81 billion, a P/E ratio of 55.55, a PEG ratio of 1.53 and a beta of 1.52.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its earnings results on Tuesday, November 12th. The company reported $0.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.08 by $0.02. Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The company had revenue of $133.50 million for the quarter, compared to analyst estimates of $138.06 million. During the same period in the prior year, the firm earned ($0.09) earnings per share. Integral Ad Science's revenue for the quarter was up 11.0% on a year-over-year basis. As a group, equities analysts expect that Integral Ad Science Holding Corp. will post 0.26 EPS for the current fiscal year.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Raymond James boosted their price objective on shares of Integral Ad Science from $13.00 to $15.00 and gave the stock an "outperform" rating in a research note on Friday, August 2nd. Piper Sandler reduced their price target on Integral Ad Science from $18.00 to $16.00 and set an "overweight" rating on the stock in a research report on Wednesday, November 13th. Benchmark restated a "hold" rating on shares of Integral Ad Science in a research report on Thursday, November 14th. Barclays upped their target price on Integral Ad Science from $12.00 to $13.00 and gave the company an "equal weight" rating in a report on Monday, August 5th. Finally, Craig Hallum lowered their price target on shares of Integral Ad Science from $18.00 to $16.00 and set a "buy" rating for the company in a report on Wednesday, November 13th. Three analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, Integral Ad Science has a consensus rating of "Moderate Buy" and a consensus target price of $15.70.

Insider Buying and Selling at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 10,481 shares of the stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $10.11, for a total value of $105,962.91. Following the completion of the sale, the chief executive officer now owns 239,709 shares in the company, valued at $2,423,457.99. This represents a 4.19 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Tania Secor sold 5,240 shares of the stock in a transaction dated Monday, October 7th. The shares were sold at an average price of $10.11, for a total transaction of $52,976.40. Following the completion of the sale, the chief financial officer now owns 248,223 shares of the company's stock, valued at approximately $2,509,534.53. This trade represents a 2.07 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 23,006 shares of company stock valued at $240,296. Corporate insiders own 2.00% of the company's stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.